Filing Details
- Accession Number:
- 0001354488-16-005954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-21 21:10:27
- Reporting Period:
- 2016-01-19
- Filing Date:
- 2016-01-21
- Accepted Time:
- 2016-01-21 21:10:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1569877 | K Andrew Chan | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-19 | 1,516 | $5.61 | 147,273 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-19 | 1,516 | $12.07 | 145,757 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-01-21 | 1,296 | $3.00 | 147,053 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-21 | 1,296 | $13.87 | 145,747 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non- Qualified Stock Option (right to buy) (2013 Plan) | Disposition | 2016-01-19 | 1,516 | $0.00 | 1,516 | $5.61 |
| Common Stock | Non- Qualified Stock Option (right to buy) (2011 Plan) | Disposition | 2016-01-21 | 1,296 | $0.00 | 1,296 | $3.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,420 | 2023-05-16 | No | 4 | M | Direct | |
| 40,187 | 2023-02-20 | No | 4 | M | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- On December 22, 2015, due to miscommunications with regard to the nature of transactions undertaken by the reporting person in September 2015, the reporting person mistakenly reported the number of shares of common stock and derivative securities of the issuer owned by him after certain transactions undertaken in December 2015. As a result, the number of outstanding securities owned by the reporting person after each transaction as reported on this form reflects corrections of the reporting errors made in December 2015.
- The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.
- The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.
Billionaire Hedge Funds
